Related Experiment Videos

Physician/patient decision aids for adjuvant therapy

Timothy J Whelan¹, Charles Loprinzi

¹Juravinski Cancer Centre, 699 Concession St, Room 3-62, Hamilton, Ontario, L8V 5C2 Canada. tim.whelan@hrcc.on.ca

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|March 10, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32.

JNCI cancer spectrum·2026

Exploration of BMI and circulating metabolic factors as predictors of metformin benefit in CCTG MA.32.

JNCI cancer spectrum·2026

Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

JCO oncology advances·2026

Stereotactic Versus Conventional Radiotherapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer: A Bayesian Reanalysis of the LUSTRE Randomized Trial.

Clinical lung cancer·2026

Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE Trial.

International journal of radiation oncology, biology, physics·2025

Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.

Breast cancer research and treatment·2025

See all related articles